EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 18, Issue 1
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Europe

PROSTATE CANCER DRUG BYPRODUCT CAN FUEL CANCER CELLS, UNITED STATES-BASED RESEARCHERS FIND

A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to new research in the United Sta...
18 July 2018 Europe | North America byproduct | cancer
Continue Reading →
Europe

Speeding Drug Development with Clinical Trials in a Dish

The average time to bring a new drug to market is 12 years—assuming it makes it through the rigorous regulatory hurdles. Any technology or methodology that can exped...
6 June 2018 Europe clinical | development
Continue Reading →
Europe

AstraZeneca won’t submit lung drug for COPD after 2nd study miss

AstraZeneca no longer plans to seek approval of its new respiratory biologic Fasenra in chronic obstructive pulmonary disease (COPD) after the second of two Phase...
6 June 2018 Europe 2nd | AstraZeneca
Continue Reading →
Europe

Redx Pharma up as it confirms cancer drug clinical trial will re-start early next year

Redx is developing a new generation of cancer drug called a porcupine inhibitor After discussions with the re...
31 May 2018 Europe cancer | clinical
Continue Reading →
Asia Pacific

India’s drug regulator expects to finalize new clinical trial rules in two months

India’s drug regulator plans to finalize new rules for clinical trials in a couple of months that would shorten the review time, a senior official said on Wednesday, ...
31 May 2018 Asia Pacific | Europe clinical | drug
Continue Reading →
Australasia

Bionomics begins phase II clinical trial of drug for treating agitation

No approved treatments currently available for agitation Bionomics will recruit about 40 elderly patients in ...
23 May 2018 Australasia | Europe agitation | Bionomics
Continue Reading →
Europe

Virtual drug trials boost results

Belinda H. Tan '96 says virtual drug trials can result in more diverse testing populations and boost non-white particip...
2 May 2018 Europe boosts | drug
Continue Reading →
Asia Pacific

Singapore, with strict drug laws, to develop synthetic marijuana compounds

Singapore is funding research on medical treatments containing synthetically-derived compounds of the marijuana plant Singapore, known for some of the world's most ...
2 May 2018 Asia Pacific | Europe drug | Epidiolex
Continue Reading →
Europe

High Point Company’s Alzheimer’s Drug Trial Fails

The drug was in development for close to two decades. Experts say that without new drugs, Alzheimer’s efforts will need to focus on prevention. High Point-based vTv T...
11 April 2018 Europe | Uncategorized Alzheimer's | company
Continue Reading →
Asia Pacific

Janssen to begin phase 2 clinical trials of Hanmi Pharma’s diabetes drug

US pharmaceutical company Janssen will start carrying out phase 2 clinical trials in the US to evaluate the efficacy and safety of a diabetes drug candidate originall...
4 April 2018 Asia Pacific | Europe clinical | diabetes
Continue Reading →
Catalyst: 12th January 2026
Quotient

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte